Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease

Goldstein, R.S.; Todd, T.R.J.; Guyatt, G.; Keshavjee, S.; Dolmage, T.E.; van Rooy, S.; Krip, B.; Maltais, F.; LeBlanc, P.; Pakhale, S.; Waddell, T.K.
May 2003
Thorax;May2003, Vol. 58 Issue 5, p405
Academic Journal
Background: The clinical value of LVRS has been questioned in the absence of trials comparing it with pulmonary rehabilitation, the prevailing standard of care in COPD. Patients with heterogeneous emphysema are more likely to benefit from volume reduction than those with homogeneous disease. Disease specific quality of life is a responsive interpretable outcome that enables health professionals to identify the magnitude of the effect of an intervention across several domains. Methods: Non-smoking patients aged <75 years with severe COPD (FEV[sub 1] <40% predicted, FEV[sub 1]/FVC <0.7), hyperinflation, and evidence of heterogeneity were randomized to surgical or control groups after pulmonary rehabilitation and monitored at 3 month intervals for 12 months with no crossover between the groups. The primary outcome was disease specific quality of life as measured by the Chronic Respiratory Questionnaire (CRQ). Treatment failure was defined as death or functional decline (fall of 1 unit in any two domains of the CRQ). Secondary outcomes included pulmonary function and exercise capacity. Results: LVRS resulted in significant between group differences in each domain of the CRQ at 12 months (change of 0.5 represents a small but important difference): dyspnoea 1.9 (95% confidence interval (CI) 1.3 to 2.6; p<0.0001); emotional function 1.5 (95% CI 0.9 to 2.1; p<0.0001); fatigue 2.0 (95% CI 1.4 to 2.6; p<0.0001 ); mastery 1.8 (95% CI 1.2 to 2.5; p<0.0001). In the control group one of 27 patients died and 16 experienced functional decline over 12 months. In the surgical group four of 28 patients died and three experienced functional decline (hazard ratio = 3.1 (95% CI 1.3 to 7.6; p=0.01). Between group improvements (p<0.05)in lung volumes, flow rates, and exercise were sustained at 12 months (RV -47% predicted (95% CI -71 to -23; p=0.0002); FEV[sub 1] 0.3 I (95% CI 0.1 to 0.5; p=0.0003); submaximal exercise 7.3 min (95% CI 3.9 to 10.8; p<0.0001); 6 minute walk 66 metres...


Related Articles

  • Chronic obstructive pulmonary disease · 2: Pathology and biochemistry of emphysema. Hogg, J.C.; Senior, R.M. // Thorax;Sep2002, Vol. 57 Issue 9, p830 

    Part 2. Examines the pathology and biochemistry of emphysema. Cells responsible for the degradation of extracellular matrix in emphysema; Proteinase-antiproteinase hypothesis; Proteinases involved in alveolar septal destruction.

  • Long-term results of lung volume reduction surgery Fujimoto, T.; Teschler, H.; Hillejan, L.; Zaboura, G.; Stamatis, G. // European Journal of Cardio-Thoracic Surgery;Mar2002, Vol. 21 Issue 3, p483 

    Objective: Lung volume reduction surgery (LVRS) is effective in the short and intermediate term for the improvement of pulmonary function and subjective symptoms in selected patients with advanced emphysema. The purpose of this study was to examine the long-term functional results of LVRS and to...

  • Killer Emphysema. Roberson, Delores // Saturday Evening Post;Dec84, Vol. 256 Issue 9, p4 

    Presents two readers' reactions to an article on pulmonary emphysema published in the September 1984 issue of "The Saturday Evening Post" periodical.

  • COPD: small airway obstruction and emphysema.  // African Journal of Respiratory Medicine;Mar2012, Vol. 7 Issue 2, p2 

    The article presents a study led by a team in Canada and the U.S. involving high-resolution computed tomography (CT) on people with severe chronic obstructive pulmonary disease (COPD) may lead to changes in the definition of emphysema.

  • NURSING DECISIONS: EXPERIENCES IN CLINICAL PROBLEM SOLVING. de Tornyay, Rheba; Sordelett, Starr S.; Jackson, Bettie S. // RN;Mar77, Vol. 40 Issue 3, p61 

    Presents a clinical problem solving case for nurses. Information on the patient; Diseases that comprised the chronic obstructive pulmonary disease; Risk factors of emphysema.

  • Elasticity of the Lung in Pulmonary Emphysema. Ebert, Richard V. // Annals of Internal Medicine;Nov68, Vol. 69 Issue 5, p903 

    Focuses on a study which described the elastic properties of the lungs for the incidence of pulmonary emphysema. Use of the pressure volume curve in determining the elasticity of the lungs; Analysis of the elastic properties of the normal lung; Changes in elastic properties when emphysema...

  • Surgical approaches for lung volume reduction in emphysema. CRAWFORD, EMMA; SRINIVASAN, KOOTTALAI; MOUDGIL, HARMESH; NAICKER, THIRUMALAIRENGARAJAN; AHMAD, NAWAID // Clinical Medicine;Oct2014, Vol. 14 Issue 5, p558 

    A letter to the editor is presented in response to the article related to lung volume reduction surgery (LVRS) by S. J. Clark and others in the December 10, 2013 issue.

  • Every Breath You Take. Lewis, Carol // FDA Consumer;Mar/Apr99, Vol. 33 Issue 2, p9 

    Focuses on emphysema, a degenerative disease of the lungs. Causes of the disease; Symptoms and signs; Treatment options for emphysema patients; Key to management of emphysema.

  • Breathless? Easily tired? Could be COPD.  // Telegraph (Calcutta, India);9/2/2015, p10 

    The article discusses respiratory condition chronic obstructive pulmonary disease (COPD) which encompasses emphysema and bronchitis and is caused by smoking and second hand smoke.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics